About Partners Intelligence Log in →
Demo - Europe Defense Tech Ecosystem
Log in

Geneus SAS (registered as Geneus Biotech SAS; brand Geneus®)

LiquidBlackout / LiquidVector biodefense and biointrusion systems, restricted to authorised government buyers.

Paris, France
1-10

Vitality Radar

46
Current
Industry
Updated 10 days ago

Pillar Analysis

Presence
Digital footprint, brand visibility, and online reach across channels
48
Business
Revenue signals, funding status, partnerships, and market traction
52
Innovation
R&D activity, patents, product launches, and technology adoption
46
Pulse
Recent momentum — hiring trends, news mentions, and social engagement
44
Capacity
Team strength, leadership depth, and organizational scale
41

Strategic Assessment

Strategic Vector

Geneus SAS appears to be positioning as a niche French biotech/climate-tech venture with IP-heavy, export-controlled product themes and a small international footprint. The observable signal set suggests an early-stage company focused on technical differentiation rather than scale, with limited public transparency on commercialization.

Efficiency Ratio

The company shows a potentially high IP-to-headcount model, but external proof of revenue, customer traction, and operating scale is limited, indicating modest current output relative to likely R&D effort.

Evidence Signals

Other HIGH Paris, France

LinkedIn describes Geneus® as a privately held climate technology product manufacturing company founded in 2017 with 11-50 employees and specialties including biotechnology, cellular agriculture, genomics, and biointrusion.

View source
Other HIGH Paris, France

LinkedIn lists product/IP themes including IP-protected cell-based fur and wool, wool and feather recycling, and branded offerings such as FUROID®, LiquidWool™, LiquidFeather™, and LiquidFur™.

View source
Other MEDIUM France

The company website exists under the Geneus.fr domain, indicating an active branded web presence for the French entity.

View source
Other HIGH Paris, France

French corporate listings identify GENEUS BIOTECH as a Paris SAS registered in June 2023 with NAF/APE 7211Z, which is consistent with biotechnology R&D activity.

View source
Other MEDIUM Paris, France / Berlin, Germany

The company uses a Paris headquarters and also lists a Berlin location on LinkedIn, suggesting some cross-border operational footprint.

View source
Other MEDIUM

No public evidence in the provided results shows funding rounds, major customer logos, or published revenue figures for the French Geneus entity, limiting traction visibility.

About
Geneus SAS, registered as Geneus Biotech SAS in the 7th arrondissement of Paris with EUR 50,000 share capital, markets LiquidBlackout and LiquidVector as a biodefense and biointrusion system, available only to authorised government, military and law-enforcement customers subject to export-control screening. Everything known comes from the company's own pages; the gap between the scale of the claim and the size of the entity is the reason to verify before relying on this record.
Relevancy
Its own product page carries a named, dedicated defense product line (LiquidBlackout / LiquidVector, a 'biodefense/biointrusion system') with access restricted to authorised government/military/law-enforcement customers including export-control screening. More than an application-list mention (not a pure EPIGAP case) but resting exclusively on self-presentation. Anchor A2 (self-declaration only). Classified C12-08.
Tags
#Biodefense #CBRN #Biointrusion #LiquidBlackout #ExportControlled #GatedProduct #France

Suggest an edit

Footer

Demo - Europe Defense Tech Ecosystem

Powered by Meschonomy

Terms Privacy Contact